Zobrazeno 1 - 10
of 421
pro vyhledávání: '"Antolín, C."'
Autor:
Prior-de Castro C; Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain. Electronic address: carmen.prior@salud.madrid.org., Martínez Gallego MÁ; Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain., Gómez-González C; Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain., de Sancho Martín R; Department of Molecular Genetics-INGEMM, La Paz University Hospital, Servicio de Genética Bloque Quirúrgico, Planta -2, Paseo de la Castellana, Madrid 261 28046, Spain., Rodríguez-Antolín C; Biomarkers and Experimental Therapeutics in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain., Rodríguez-Jiménez C; Department of Next-Generation Sequencing-INGEMM, La Paz University Hospital, Madrid, Spain., Del Pozo Mate Á; Department of Bioinformatics-INGEMM, La Paz University Hospital, Madrid, Spain., Zamarrón de Lucas E; Department of Pulmonology, La Paz University Hospital, Madrid, Spain., Ruiz de Valbuena Maiz M; Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital La Paz Institute for Health Research - IdiPAZ, Madrid, Spain., de Manuel Gómez C; Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital La Paz Institute for Health Research - IdiPAZ, Madrid, Spain., Alcolea Batres S; Department of Pulmonology, La Paz University Hospital, Madrid, Spain., Prados Sánchez MC; Department of Pulmonology, La Paz University Hospital, Madrid, Spain., J Torres R; La Paz University Hospital Health Research Institute (FIBHULP), IdiPAZ, Madrid, Spain, Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Spain.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jul; Vol. 23 (4), pp. 788-795. Date of Electronic Publication: 2023 Dec 26.
Autor:
Rosas-Alonso R; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain. rosas.alonso.rocio@gmail.com.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain. rosas.alonso.rocio@gmail.com., Colmenarejo-Fernández J; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Pernía O; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Burdiel M; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Rodríguez-Antolín C; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Losantos-García I; Biostatistics Unit, IdiPaz, Madrid, Spain., Rubio T; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Moreno-Velasco R; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain., Esteban-Rodríguez I; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Department of Pathology, La Paz University Hospital, Madrid, Spain., Martínez-Marín V; Department of Medical Oncology, La Paz University Hospital, Madrid, Spain., Yubero P; Department of Medical Oncology, La Paz University Hospital, Madrid, Spain., Costa-Fraga N; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), IDIS, University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain., Díaz-Lagares A; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), IDIS, University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., López-López R; Cancer Epigenomics Laboratory, Epigenomics Unit, Translational Medical Oncology Group (ONCOMET), IDIS, University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain., Díaz-Martin E; MD Anderson International Foundation, Madrid, Spain., García JF; MD Anderson International Foundation, Madrid, Spain.; Department of Pathology, MD Anderson Cancer Center, Madrid, Spain., Sánchez CV; Department of Neurosurgery, La Paz University Hospital, Madrid, Spain., Gandía-González ML; Department of Neurosurgery, La Paz University Hospital, Madrid, Spain., Moreno-Bueno G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; MD Anderson International Foundation, Madrid, Spain.; Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ, Madrid, Spain., de Castro J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Department of Medical Oncology, La Paz University Hospital, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., de Cáceres II; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Paseo La Castellana 261, Edificio Bloque Quirúrgico Planta-2, 28046, Madrid, Spain. inma.ibanezca@salud.madrid.org.; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain. inma.ibanezca@salud.madrid.org.
Publikováno v:
Scientific reports [Sci Rep] 2024 May 18; Vol. 14 (1), pp. 11398. Date of Electronic Publication: 2024 May 18.
Autor:
Garcia, A., Vera, O., Sanchez-Cabrero, D., Gutierrez, L., Higueras, O., Esteban, I., Rodriguez-Antolín, C., Losantos, I., De Castro, J., De Caceres, I. Ibanez
Publikováno v:
In The Journal of Liquid Biopsy November 2023 1 Supplement
Autor:
De Caceres, I. Ibanez, Rosas-Alonso, R., Pernia, O., Burdiel, M., Rodriguez-Antolin, C., Moreno, R., Esteban-Rodriguez, I., Martinez, V., de Castro, J.
Publikováno v:
In The Journal of Liquid Biopsy November 2023 1 Supplement
Autor:
Gutiérrez Sainz, L., Ozáez, I., Higuera Gómez, O., Villamayor, J., Esteban Rodríguez, I., Regojo Zapata, R.M., Peláez García, A., Heredia Soto, V., Mendiola, M., Rosas Alonso, R., Rodríguez Antolín, C., Ibáñez de Cáceres, I., de Castro Carpeño, J.
Publikováno v:
In Journal of Thoracic Oncology October 2024 19(10) Supplement:S649-S649
Autor:
Sánchez-Cazorla E; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., González-Atienza C; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., López-Vázquez A; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Arruti N; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain., Nieves-Moreno M; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain., Noval S; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain., Mena R; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain., Rodríguez-Jiménez C; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Rodríguez-Solana P; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., González-Iglesias E; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Guerrero-Carretero M; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., D'Anna Mardero O; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Coca-Robinot J; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Acal JC; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Blasco J; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Castañeda C; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Fraile Maya J; Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain., Del Pozo Á; Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain.; Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain., Gómez-Pozo MV; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain., Montaño VEF; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain., Dios-Blázquez L; Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain., Rodríguez-Antolín C; Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain., Gómez-Cano MLÁ; Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain., Delgado-Mora L; Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain., Vallespín E; Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.; European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain.; Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 27; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 27.
Autor:
Burdiel M; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Jiménez J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Rodríguez-Antolín C; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., García-Guede Á; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Pernía O; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Sastre-Perona A; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Rosas-Alonso R; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Colmenarejo J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Rodríguez-Jiménez C; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Diestro MD; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain., Martínez-Marín V; Medical Oncology Department, La Paz University Hospital, Madrid, Spain., Higueras O; Medical Oncology Department, La Paz University Hospital, Madrid, Spain., Cruz P; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain., Losantos-García I; Biostatistics Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain., Peinado H; Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain., Vera O; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain. olga.vera@salud.madrid.org.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain. olga.vera@salud.madrid.org., de Castro J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain.; Medical Oncology Department, La Paz University Hospital, Madrid, Spain., Ibáñez de Cáceres I; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, Madrid, Spain. inma.ibanezca@gmail.com.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, Madrid, Spain. inma.ibanezca@gmail.com.
Publikováno v:
Biomarker research [Biomark Res] 2023 Oct 20; Vol. 11 (1), pp. 94. Date of Electronic Publication: 2023 Oct 20.
Autor:
Stewart S; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain., Dodero-Anillo JM; Clinical Pharmacology, Hospital Universitario Puerto Real, Cadiz, Spain., Guijarro-Eguinoa J; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain., Arias P; Pharmacogenetics Laboratory, Genetics Department, La Paz University Hospital, Madrid, Spain., Gómez López De Las Huertas A; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain., Seco-Meseguer E; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain., García-García I; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain., Ramírez García E; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain.; Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Rodríguez-Antolín C; Experimental Therapies and Novel Biomarkers in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain.; Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Rodriguez-Novoa S; Genetics of Metabolic Diseases Laboratory, Genetics Department, La Paz University Hospital, Madrid, Spain., Rosas-Alonso R; Pharmacogenetics Laboratory, Genetics Department, La Paz University Hospital, Madrid, Spain.; Experimental Therapies and Novel Biomarkers in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital, Madrid, Spain.; Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Oct 19; Vol. 14, pp. 1292416. Date of Electronic Publication: 2023 Oct 19 (Print Publication: 2023).
Autor:
Ibáñez-Navarro M; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Fernández A; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Escudero A; Pediatric Oncology Department, Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain., Esteso G; Tumor Immune Activation and Evasion Lab. Immunology and Oncology Department, National Biotechnology Center (CNB), Madrid, Spain., Campos-Silva C; Tumor Immune Activation and Evasion Lab. Immunology and Oncology Department, National Biotechnology Center (CNB), Madrid, Spain., Navarro-Aguadero MÁ; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Leivas A; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Caracuel BR; Pediatric Oncology Department, Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, Spain., Rodríguez-Antolín C; Biomarkers and Experimental Therapeutics in Cancer, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain.; Cancer Epigenetics Laboratory, Genetic Unit, Hospital Universitario La Paz, Madrid, Spain., Ortiz A; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Navarro-Zapata A; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain., Mestre-Durán C; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain., Izquierdo M; Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain., Balaguer-Pérez M; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Ferreras C; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain., Martínez-López J; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Valés-Gómez M; Tumor Immune Activation and Evasion Lab. Immunology and Oncology Department, National Biotechnology Center (CNB), Madrid, Spain., Pérez-Martínez A; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.; Pediatric Hemato-Oncology, Hospital Universitario La Paz, Madrid, Spain.; Pediatric Department, Universidad Autónoma de Madrid, Madrid, Spain., Fernández L; Hematological Malignancies-H12O Lab. Clinical Research Department, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Oct 18; Vol. 14, pp. 1187665. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients.
Autor:
Sanchez-Cabrero D; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Medical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain., Garcia-Guede Á; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Burdiel M; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Pernía O; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Colmenarejo-Fernandez J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Gutierrez L; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Medical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain., Higuera O; Medical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain., Rodriguez IE; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Pathology Department, La Paz University Hospital, 28046 Madrid, Spain., Rosas-Alonso R; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Rodriguez-Antolín C; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., Losantos-García I; Biostatistics Unit, La Paz University Hospital, 28046 Madrid, Spain., Vera O; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain., De Castro-Carpeño J; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Medical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain., Ibanez de Caceres I; Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.; Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 14; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 14.